Surface Oncology

Surface Oncology Overview

Founded 2014
Founded
Status Public
Employees 49
Employees
Stock Symbol SURF
Stock Symbol
Share Price $5.11 (As of Friday Closing)

Surface Oncology General Information

Description

Surface Oncology Inc is a clinical-stage immuno-oncology company. It is developing new therapies that modify the spaces in and around tumors the tumor microenvironment to create conditions that support and sustain anti-tumor immune responses. The company's pipeline products are SRF231, SRF373, SRF617, and SRF388. Geographically, the activities are carried out through the region of the United States.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 50 Hampshire Street
  • 8th Floor
  • Cambridge, MA 02139
  • United States
+1 (617) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Surface Oncology Stock Performance

(As of Tuesday closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$5.11 $4.89 $1.15 - $7.66 $145M 28.3M 1.87M -$1.01

Surface Oncology Financials Summary

In Thousands,
USD
TTM 31-Mar-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV (27,648) (38,504) (56,004)
Revenue 39,518 15,360 59,417 12,826
EBITDA (28,069) (55,581) (7,804) (45,026)
Net Income (28,020) (54,789) (6,597) (45,377)
Total Assets 131,215 131,693 174,065 81,454
Total Debt 40,271 25,039 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Surface Oncology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Surface Oncology‘s full profile, request access.

Request a free trial

Surface Oncology Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Surface Oncology‘s full profile, request access.

Request a free trial

Surface Oncology Competitors (20)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
OncoResponse Venture Capital-Backed Seattle, WA 00 000.00 00000000000 000.00
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
0000 000000000000 Formerly VC-backed Cambridge, MA 00 00000 000000 - 000 00000
0000 000000 Formerly VC-backed San Diego, CA 00 00000 000000 - 000 00000
0000000 0000000000 Formerly VC-backed Redwood City, CA 00 00000 000000&0 00000

Surface Oncology Executive Team (14)

Name Title Board Seat Contact Info
Jeffrey Goater Chief Executive Officer & Board Member
Jessica Fees Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Liisa Nogelo Chief Legal Officer
Vito Palombella Chief Scientific Officer
Wendy Dwyer Executive

3 Former Executives

Surface Oncology Board Members (14)

To view Surface Oncology‘s full board member team, request access >>
Name Representing Role Since
Armen Shanafelt Ph.D Lilly Ventures Board Member 000 0000
Chris Klee Self Board Observer 000 0000
Daniel Lynch Surface Oncology Chairman & Board Member 000 0000
David Grayzel MD Atlas Venture Founder & Board Member 000 0000
Elliott Sigal Ph.D New Enterprise Associates Board Member & Member of Nominating, Corporate Governance Committee 000 0000

3 Former Board Members

Surface Oncology Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Surface Oncology‘s full profile, request access.

Request a free trial